Umbilical Cord Blood Transplant for Children With Myeloid Hematological Malignancies
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Fludarabine
Related studies linked through entity extraction aliases.
Umbilical Cord Blood Transplant for Children With Lymphoid Hematological Malignancies
- Status
- WITHDRAWN
- Phase
- NA
Cell Therapy for Metastatic Melanoma Using CD8 Enriched Tumor Infiltrating Lymphocytes
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
CAR T Cell Receptor Immunotherapy Targeting VEGFR2 for Patients With Metastatic Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Reduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Once Daily Targeted Intravenous (IV) Busulfex as Part of Reduced-toxicity Conditioning for Patients With Refractory Lymphomas Undergoing Allogeneic Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic Anemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Fludarabine, Velcade and Rituximab for Relapsed or Refractory Follicular Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Penostatin, Rituximab and Ontak and Allogeneic Natural Killer (NK) Cells for Refractory Lymphoid Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Dasatinib With Fludarabine and Rituximab in Relapsed and Refractory CLL and SLL
- Status
- TERMINATED
- Phase
- PHASE2
T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
A Study of MabThera (Rituximab) Addition to Regularly Prescribed Chemotherapy in Patients With Untreated Mantle Cell Lymphoma.
- Status
- TERMINATED
- Phase
- PHASE2
Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers
- Status
- TERMINATED
- Phase
- PHASE2
HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Haploidentical Natural Killer Cells to Treat Refractory or Relapsed Acute Myelogenous Leukemia (AML)
- Status
- TERMINATED
- Phase
- PHASE2
Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Aplastic Anemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Fludarabine, Bendamustine, and Rituximab (FBR) for Relapsed Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2